Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2002
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002WO2002079127A1 Selective ring-opening cross-metathesis of cycloolefins
10/10/2002WO2002078699A1 Compounds and methods
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078658A1 Dyeing composition for dyeing keratinous fibres comprising a cationic azo-dye
10/10/2002WO2002078596A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
10/10/2002WO2002057215A3 Sodium channel modulators
10/10/2002WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147359 Neurokinin antagonist; antiinflammatory agents, antiallergens
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147229 Pharmaceuticals
10/10/2002US20020147228 Adjust concentration of albumin in blood
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147197 Methods and compositions for enhancing pharmaceutical treatments
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147193 Novel couplers for use in oxidative hair dyeing
10/10/2002US20020144361 Novel couplers for use in oxidative hair dyeing
10/10/2002US20020144359 Derivatives of 2-aminophenol; providing good oxidative coloration of hair and for providing acceptable light fastness, selectivity, fastness to shampooing
10/10/2002US20020144357 Benzene-1,4-diamine compounds having a weaker sensitization potential than p-phenylenediamine
10/10/2002DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002CA2442636A1 Selective ring-opening cross-metathesis of cycloolefins
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246617A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
10/09/2002EP1000025A4 Substituted naphthopyrans
10/09/2002EP0810996B1 Imidazolidinone derivatives as corrosion inhibitors
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1373663A Use of 2-imidazolyl substd, carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462221 3-substituted-3-amino-2-hydroxypropanoic acid salt or 1-nitro-3-substitute-3-amino-2-hydroxypropanol diastereomers obtained from simulated moving bed separation
10/08/2002US6462193 Adding 3-azido-2-hydroxypropanaldehyde with dihydroxyacetone phosphate using an aldolase, hydrolyzing the intermediate with acid phosphatase, isomerizing using an isomerase, cyclizing using reductive amination to produce tetrahydroxyazepine
10/08/2002US6462164 Offers a good balance of low-temperature cure and shelf stability
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462063 N,n'-disubstituted hydantoin hydroxamates; regulating, modulating and/or inhibiting abnormal collagen formation to treat fibrotic disorders; hepatic cirrhosis, arthritis
10/08/2002US6461389 Hair dye
10/03/2002WO2002077145A1 Composition and method for bleachin g a substrate
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076958A1 Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076952A1 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076613A1 High activity metal carbene metathesis catalysts generated using a thermally activated n-heterocyclic carbene precursor
10/03/2002WO2002062766A3 Melanocortin-4 receptor binding compounds and methods of use thereof
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002US20020143190 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
10/03/2002US20020143044 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143007 Donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase; for use in therapy
10/03/2002US20020142998 For prophylaxis and therapy
10/03/2002US20020142921 Oil-soluble additives for lubricating oils
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142021 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
10/03/2002US20020138919 Novel couplers for use in oxidative hair dyeing
10/03/2002CA2441500A1 High activity metal carbene metathesis catalysts generated using a thermally activated n-heterocyclic carbene precursor
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245232A1 Oral solid preparation
10/02/2002EP1244646A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
10/02/2002EP1244635A2 4-aryl-1-difluoromethoxyimidazole
10/02/2002EP1244634A1 Substituted benzoylcyclohexane diones for use as herbicides
10/02/2002EP0877730B1 Aryl acrylics for use as fungicide
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002DE10111936C1 N-Heteroarylmethyl-m-phenylendiamin-Derivate enthaltende Haarfärbemittel sowie neue N-Heteroarylmethyl-m-phenylendiamin-Derivate N-heteroarylmethyl-m-phenylenediamine derivatives, hair dyes containing as well as new N-heteroarylmethyl-m-phenylenediamine derivatives
10/02/2002CN1372551A Process for preparing 1-substituted 5-hydroxymethyl imidazole
10/02/2002CN1371908A Easter compound, method for preventing and controlling injurious insect and use of said ester compound
10/02/2002CN1371687A Hypoalbuminemia improvement agent
10/02/2002CN1091764C Pesticidal sulfur compounds
10/01/2002US6459003 Ether compounds
10/01/2002US6459001 Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458990 Nitrogen-based halogenating agents and process for preparing halogen-containing compounds
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458963 Process for preparing eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates
10/01/2002US6458960 Sulfonamide derivatives
10/01/2002US6458935 Radiolabeled farnesyl-protein transferase inhibitors
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458794 Potassium channel inhibitors
10/01/2002US6458167 Use of cationic phenyl-azo-benzene compounds for dyeing keratin fibers, dye compositions and dyeing processes
09/2002
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 345